ImmPACT Bio

ImmPACT Bio is a clinical-stage company developing transformative logic-gate based CAR T-cell therapies for treating cancer and autoimmune diseases.

Health Tech & Life Sciences
Acquired by Lyell Immunopharma
Acquired Camarillo, United States Founded 2017
Last updated 2026-07-20
Total raised
$137.0M
Last: Grant 2024-02
Stage
Acquired
Founded
2017
Headcount
49
HQ
Camarillo, United States
Sector
Health Tech & Life Sciences

About

ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients who have exhausted their treatment options. The company's logic-gate-based CAR T platforms address key biological challenges in treating cancer, specifically designed to prevent antigen escape, 'on-target - off-tumor' toxicities, and overcome the immunosuppressive tumor microenvironment. The company's technologies are based on the work of pioneering scientists Yvonne Chen, Ph.D., and Antoni Ribas, M.D., Ph.D., both from UCLA, and Gideon Gross, Ph.D., from the MIGAL-Galilee Research Institute.

Funding history · 4 rounds · $137.0M total

2024-01
Grant $8.0M
2021-12
B Round $111.0M
★ venBioOrbiMedDecheng CapitalForesite CapitalSurveyor CapitalNovartis Venture FundBukwang PharmaceuticalRMGP Biopharma Investment Fund
2020-07
A Round $18.0M
★ OrbiMed★ Takeda Ventures★ Bukwang Pharmaceutical★ RMGP Biopharma Investment Fund
2019-05
Seed Undisclosed
★ OrbiMed★ Novartis Venture Fund★ RMGP Biopharma Investment Fund

Headcount over time

From 66 (2023-02) to 33 (2026-03) · -33 (-50%) · 15 points · source: Finder history + radar grounding
1120 2023-02 2026-03

Q&A

What is ImmPACT Bio's primary focus?
ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
When was ImmPACT Bio acquired and by whom?
ImmPACT Bio was acquired by Lyell Immunopharma in October 2024.
How much funding has ImmPACT Bio raised in total?
ImmPACT Bio has raised a total of $137,000,000.
When was ImmPACT Bio founded?
ImmPACT Bio was founded in November 2016.
What was ImmPACT Bio's most recent funding round?
In February 2024, ImmPACT Bio received an $8,000,000 grant from the California Institute for Regenerative Medicine (CIRM).
Which investors participated in ImmPACT Bio's $111,000,000 funding round in January 2022?
The January 2022 funding round was led by venBio, with participation from OrbiMed.
How many employees does ImmPACT Bio have?
ImmPACT Bio has 11-50 employees.
Where is ImmPACT Bio's headquarters located?
ImmPACT Bio's headquarters is located in Rehovot, Israel, with an additional office in Los Angeles, USA.

Team · 3

Yvonne Chen
Founder · Scientific Founder
Antoni Ribas
Founder · Scientific Founder
Gideon Gross
Founder · Scientific Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

biotechnologybiopharmaceuticallife-sciencesgenetic-engineeringmedical-technologiescancer-therapyhospitalshealthcare-providersoncologycell-therapycancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteimmpact-bio.com/
LinkedInlinkedin.com/company/37527946

Identifiers & details

Legal nameImmPACT Bio USA Inc.
Founded2017-4
Employees (exact)49
OfficesLos Angeles
Status reasonAcquired by Lyell Immunopharma on Oct 2024

Acquisitions & public offerings

Acquired by Lyell Immunopharma 2024-10 $93.7M

Radar intelligence

Patents

EPO8

Web history (Wayback)

Domainimmpact-bio.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515549004
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2016-11-16
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2026
Active charges / liens0
Registry events3 — violation (1), annual_report (1), people (1)
Registered addressריבלין יוסף 22 ירושלים

Recent registry events

DateEvent
2026-06-25עדכון הפרה
2026-06-07דו~ח שנתי
2025-11-06עדכון בעלי תפקידים